<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No._____)*
MediChem Life Sciences, Inc.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
--------------------------------------------------------------------------------
(Title of Class of Securities)
584662-10-0
------------------------------
(CUSIP Number)
October 31, 2000
--------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
[_] Rule 13d-1(b)
[_] Rule 13d-1(c)
[X] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
<PAGE>
CUSIP NO. 584662-10-0
------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
Michael T. Flavin
------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [_]
(b) [X]
------------------------------------------------------------------------------
3 SEC USE ONLY
------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF
8,006,135
SHARES -----------------------------------------------------------
6 SHARED VOTING POWER
BENEFICIALLY
-0-
OWNED BY -----------------------------------------------------------
7 SOLE DISPOSITIVE POWER
EACH
8,006,135
REPORTING -----------------------------------------------------------
8 SHARED DISPOSITIVE POWER
PERSON WITH
-0-
------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
8,006,135
------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
[_]
------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
31.5%
------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
IN
------------------------------------------------------------------------------
<PAGE>
Item 1.
(a) Name of Issuer: MediChem Life Sciences, Inc.
(b) Address of Issuer's Principal Executive Offices:
12305 South New Avenue
Lemont, Illinois 60439
Item 2.
(a) Name of Person Filing: Michael T. Flavin
(b) Address of Principal Business Office:
12305 South New Avenue
Lemont, Illinois 60439
(c) Citizenship: United States of America
(d) Title of Class of Securities: Common Stock, par value $0.01
per share
(e) CUSIP Number: 584662-10-0
Item 3. Not Applicable.
Item 4. Ownership
(a) Amount Beneficially Owned: 8,006,135
(b) Percent of Class: 31.5%
The Michael T. Flavin Revocable Trust (the "Flavin Trust"), of which Dr.
Michael T. Flavin is the trustee and beneficiary, is the registered
holder of 8,006,135 shares of Common Stock. The Flavin Trust became the
registered holder of such shares of Common Stock by virtue of the closing
of the initial public offering of Common Stock of MediChem Life Sciences,
Inc. on October 31, 2000.
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote 8,006,135
(ii) shared power to vote or to direct the vote -0-
(iii) sole power to dispose or to direct the disposition of 8,006,135
(iv) shared power to dispose or to direct the disposition of -0-
Item 5. Ownership of Five Percent or Less of a Class
Not Applicable.
Item 6. Ownership of More than Five Percent on Behalf of Another Person
Not Applicable.
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on By the Parent Holding Company
Not Applicable.
Item 8. Identification and Classification of Members of the Group
Not Applicable.
<PAGE>
Item 9. Notice of Dissolution of a Group
Not Applicable.
Item 10. Certification
Not Applicable.
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
November 9, 2000
MICHAEL T. FLAVIN
By: /s/ Michael T. Flavin
-----------------------------------
Michael T. Flavin
